• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物性毛发疾病

Drug-induced hair disorders.

作者信息

Piraccini Bianca Maria, Iorizzo Matilde, Rech Giulia, Tosti Antonella

机构信息

Department of Dermatology, University of Bologna, Via Massarenti 1, Bologna, Italy.

出版信息

Curr Drug Saf. 2006 Aug;1(3):301-5. doi: 10.2174/157488606777934477.

DOI:10.2174/157488606777934477
PMID:18690941
Abstract

Drugs may induce hair loss, stimulate hair growth or, more rarely, induce changes in the hair shape and colour. Drug-induced hair loss is usually completely reversible and is, in most cases, a consequence of a toxic effect of the drug on the hair follicle matrix. In rare cases alopecia may be permanent. Depending on type of drug, dosage and patient susceptibility, hair loss presents as telogen effluvium, anagen effluvium or both. Telogen effluvium is also commonly observed after discontinuation of drugs that prolong anagen, such as topical minoxidil and oral contraceptives. Although a large number of drugs have been occasionally reported to produce hair loss, only for a few drugs the relation between drug intake and hair loss has been proven.

摘要

药物可能导致脱发、刺激头发生长,或更罕见地,引起头发形状和颜色的改变。药物性脱发通常是完全可逆的,在大多数情况下,是药物对毛囊基质产生毒性作用的结果。在极少数情况下,脱发可能是永久性的。根据药物类型、剂量和患者易感性,脱发表现为休止期脱发、生长期脱发或两者皆有。在停用延长生长期的药物(如外用米诺地尔和口服避孕药)后,也常观察到休止期脱发。尽管偶尔有大量药物被报道会导致脱发,但只有少数药物摄入与脱发之间的关系得到了证实。

相似文献

1
Drug-induced hair disorders.药物性毛发疾病
Curr Drug Saf. 2006 Aug;1(3):301-5. doi: 10.2174/157488606777934477.
2
Drug reactions affecting hair: diagnosis.影响毛发的药物反应:诊断
Dermatol Clin. 2007 Apr;25(2):223-31, vii. doi: 10.1016/j.det.2007.01.005.
3
Drug-induced hair loss and hair growth. Incidence, management and avoidance.药物性脱发与毛发生长。发生率、管理与预防
Drug Saf. 1994 Apr;10(4):310-7. doi: 10.2165/00002018-199410040-00005.
4
[Adverse drug reactions on hair].
Z Hautkr. 1990 Dec;65(12):1128-34.
5
'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.细胞毒性药物所致的“萎缩性休止期脱发”以及一项关于研究局部应用维生素D类似物预处理对人类可能的保护作用的随机对照试验。
Br J Dermatol. 2005 Jul;153(1):103-12. doi: 10.1111/j.1365-2133.2005.06608.x.
6
Anagen effluvium.生长期脱发。
Indian J Dermatol Venereol Leprol. 2013 Sep-Oct;79(5):604-12. doi: 10.4103/0378-6323.116728.
7
Drug-induced hair colour changes.
Eur J Dermatol. 2016 Dec 1;26(6):531-536. doi: 10.1684/ejd.2016.2844.
8
Anagen Effluvium生长期脱发
9
Telogen Effluvium休止期脱发
10
Drugs and hair loss.药物与脱发。
Dermatol Clin. 2013 Jan;31(1):67-73. doi: 10.1016/j.det.2012.08.002. Epub 2012 Sep 18.

引用本文的文献

1
Hair Aging and Hair Disorders in Elderly Patients.老年患者的头发老化与毛发疾病
Int J Trichology. 2022 Nov-Dec;14(6):191-196. doi: 10.4103/ijt.ijt_90_21. Epub 2023 Jan 31.
2
Direct-acting oral anticoagulants and alopecia: The valuable support of postmarketing data.直接口服抗凝剂与脱发:上市后数据的宝贵支持。
Br J Clin Pharmacol. 2020 Aug;86(8):1654-1660. doi: 10.1111/bcp.14221. Epub 2020 Feb 18.
3
Alopecia Associated with Use of Methylphenidate: A Case Series.与使用哌甲酯相关的脱发:病例系列
Indian J Psychol Med. 2018 Jul-Aug;40(4):370-371. doi: 10.4103/IJPSYM.IJPSYM_63_18.
4
Hair diseases: a big problem on a small surface.毛发疾病:小面积上的大问题。
Postepy Dermatol Alergol. 2016 Oct;33(5):317-322. doi: 10.5114/ada.2016.62834. Epub 2016 Oct 21.
5
Alopecia following oral acyclovir for the treatment of herpes simplex keratitis.口服阿昔洛韦治疗单纯疱疹性角膜炎后出现脱发。
Middle East Afr J Ophthalmol. 2014 Jan-Mar;21(1):95-7. doi: 10.4103/0974-9233.124131.
6
The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias.前列腺素相关青光眼治疗药物比马前列素为治疗头皮脱发提供了一种新方法。
FASEB J. 2013 Feb;27(2):557-67. doi: 10.1096/fj.12-218156. Epub 2012 Oct 26.